RU93058449A - Hcv геномные последовательности для диагностических и терапевтических целей - Google Patents

Hcv геномные последовательности для диагностических и терапевтических целей

Info

Publication number
RU93058449A
RU93058449A RU93058449/14A RU93058449A RU93058449A RU 93058449 A RU93058449 A RU 93058449A RU 93058449/14 A RU93058449/14 A RU 93058449/14A RU 93058449 A RU93058449 A RU 93058449A RU 93058449 A RU93058449 A RU 93058449A
Authority
RU
Russia
Prior art keywords
diagnostic
therapeutic purposes
genomic sequences
hcv genomic
hcv
Prior art date
Application number
RU93058449/14A
Other languages
English (en)
Other versions
RU2155228C2 (ru
Inventor
ЧА Тай-Ан
БИЛЛ Ейлин
ИРВИН Брюс
Берг Джэнис
С.Урдеа Майкл
Original Assignee
Чирон Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Чирон Корпорейшн filed Critical Чирон Корпорейшн
Publication of RU93058449A publication Critical patent/RU93058449A/ru
Application granted granted Critical
Publication of RU2155228C2 publication Critical patent/RU2155228C2/ru

Links

Claims (1)

  1. В изобретении представлены композиции нуклеиновой кислоты, пептида и антитела, относящиеся к генотипам вируса гепатита С и к способам использования таких композиций для диагностических и терапевтических целей.
RU93058449/13A 1991-05-08 1992-05-08 Hcv геномные последовательности для диагностических и терапевтических целей RU2155228C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69732691A 1991-05-08 1991-05-08
US697,326 1991-05-08

Publications (2)

Publication Number Publication Date
RU93058449A true RU93058449A (ru) 1996-11-10
RU2155228C2 RU2155228C2 (ru) 2000-08-27

Family

ID=24800701

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93058449/13A RU2155228C2 (ru) 1991-05-08 1992-05-08 Hcv геномные последовательности для диагностических и терапевтических целей

Country Status (20)

Country Link
EP (2) EP0585398B1 (ru)
JP (7) JPH06508026A (ru)
KR (1) KR100193801B1 (ru)
AT (1) ATE252154T1 (ru)
BG (3) BG62142B1 (ru)
CA (1) CA2108466C (ru)
CZ (2) CZ288720B6 (ru)
DE (1) DE69233234T2 (ru)
DK (1) DK0585398T3 (ru)
ES (1) ES2207633T3 (ru)
FI (1) FI115725B (ru)
HU (1) HU227548B1 (ru)
IE (1) IE921482A1 (ru)
NO (1) NO309532B1 (ru)
PL (2) PL169880B1 (ru)
PT (1) PT100472B (ru)
RO (1) RO117267B1 (ru)
RU (1) RU2155228C2 (ru)
SK (1) SK284205B6 (ru)
WO (1) WO1992019743A2 (ru)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5428145A (en) * 1991-08-09 1995-06-27 Immuno Japan, Inc. Non-A, non-B, hepatitis virus genome, polynucleotides, polypeptides, antigen, antibody and detection systems
EP0532167A3 (en) * 1991-08-09 1993-03-31 Immuno Japan Inc. Non-a, non-b hepatitis virus genome, polynucleotides, polypeptides, antigen, antibody and detection systems
EP0532258A2 (en) * 1991-09-09 1993-03-17 Immuno Japan Inc. Oligonucleotides and determination system of HCV genotypes
US5763159A (en) 1991-11-21 1998-06-09 Common Services Agency Hepatitis-C virus testing
US6709828B1 (en) 1992-03-06 2004-03-23 N.V. Innogenetics S.A. Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
US6667387B1 (en) 1996-09-30 2003-12-23 N.V. Innogenetics S.A. HCV core peptides
EP1262560A2 (en) * 1992-05-29 2002-12-04 Abbott Laboratories Method of forming cDNA from an RNA target sequence present in a sample
NZ286209A (en) * 1992-09-10 2000-09-29 Isis Pharmaceuticals Inc Use of HCV RNA anti-sense nucleotide sequences for treating Hepatitis C virus related disease
US6423489B1 (en) * 1992-09-10 2002-07-23 Isis Pharmaceuticals, Inc. Compositions and methods for treatment of Hepatitis C virus-associated diseases
US5846704A (en) 1992-11-27 1998-12-08 N.V. Innogenetics S.A. Process for typing of HCV isolates
JPH06153961A (ja) * 1992-11-27 1994-06-03 Imuno Japan:Kk C型肝炎ウイルス部分遺伝子、ならびにc型肝炎ウイルス遺 伝子の高感度検出法
US7258977B1 (en) 1992-11-27 2007-08-21 Innogenetics N.V. Process for typing of HCV isolates
US7255997B1 (en) 1993-04-27 2007-08-14 N.V. Innogenetics S.A. Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
US6762024B2 (en) 1993-04-27 2004-07-13 Innogenetics, S.A. Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
JPH0775585A (ja) * 1993-06-14 1995-03-20 Immuno Japan:Kk C型肝炎ウイルス関連オリゴヌクレオチドならびにc型肝炎 ウイルス遺伝子型判定方法
US7070790B1 (en) 1993-06-29 2006-07-04 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and deduced amino acid sequences of the envelope 1 and core genes of isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
US5882852A (en) * 1993-06-29 1999-03-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Hepatitic C virus (HCV) core gene nucleotide sequences and related methods of detecting major and minor genotypes of HCV isolates
US5514539A (en) 1993-06-29 1996-05-07 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
WO1995011918A1 (fr) * 1993-10-29 1995-05-04 Srl, Inc. Compose peptidique antigenique et methode de dosage immunologique
EP0759979A4 (en) * 1994-05-10 1999-10-20 Gen Hospital Corp ANTISENSE OLIGONUCLEOTIDES INHIBITION OF HEPATITIS C VIRUS
ES2176342T5 (es) 1994-10-21 2010-02-09 Innogenetics N.V. Secuencias del genotipo 7 del virus de la hepatitis c y su utilizacion como agentes profilacticos, terapeuticos y de diagnosticos.
US5851759A (en) * 1996-04-19 1998-12-22 Chiron Corporation Heteroduplex tracking assay (HTA) for genotyping HCV
IT1284847B1 (it) * 1996-06-07 1998-05-22 Sorin Biomedica Diagnostics Sp Procedimento per la rivelazione di acidi nucleici specifici di hcv
CA2308368C (en) 1997-11-04 2009-01-20 Roche Diagnostics Gmbh Specific and sensitive nucleic acid detection method
US6680059B2 (en) 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US6858590B2 (en) 2000-08-17 2005-02-22 Tripep Ab Vaccines containing ribavirin and methods of use thereof
KR20070114209A (ko) 2000-08-17 2007-11-29 트리펩 아베 리바비린 함유 백신 및 이것의 사용 방법
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
US6586584B2 (en) 2001-01-29 2003-07-01 Becton, Dickinson And Company Sequences and methods for detection of Hepatitis C virus
US7196183B2 (en) 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
US8124747B2 (en) 2003-08-29 2012-02-28 Innogenetics HCV clade and prototype sequences thereof
WO2005067643A2 (en) 2004-01-07 2005-07-28 Third Wave Technologies, Inc. Determination of hepatitis c virus genotype
KR100733186B1 (ko) * 2005-05-31 2007-06-27 재단법인 목암생명공학연구소 Hcv 유전자에 특이적인 작은 간섭 rna 및 그를유효성분으로 포함하는 c형 간염 치료제
EP2185195A2 (en) 2007-08-16 2010-05-19 Tripep Ab Immunogen platform

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR8807310A (pt) * 1987-11-18 1990-03-13 Chiron Corp Polinucleotidio,polinucleotidio recombinante,vetor recombinante,celula hospedeira,sistema de expressao recombinante,celula transformada,polipeptidio,hcv,preparacao de polipeptidio,polipeptidio de hcv,polipeptidio purificado,polipeptidio recombinante,polipeptidio de fusao,anticorpo monoclonal,preparacao purificada de anticorpos policlonais,particula,sonda de polinucleotidio,kit anticorpo para epetopo de hcv,metodo para producao de polipeptidio,metodo para deteccao de acidos nucleicos de hcv,imunoensaio para detectar antigeno de hcv,imunoensaio para detectar anticorpos dirigidos contra antigeno de hcv,vacina para tratamento de infeccao de hcv,celula,celula infectada com hcv,metodo para producao de anticorpos para hcv e metodo para isolar cdna derivado do genoma de um agente infeccioso nao identificado
UA50829C2 (ru) * 1989-03-17 2002-11-15 Чірон Корпорейшн Полинуклеотид, вектор, клетки, система экспрессии, полипептиды, моноклональные антитела, препарат поликлональных антител, нуклеотидная проба, аналитические наборы, способ выявления нуклеиновых кислот, способы иммуноанализа, вакцина, способ получения антител
GB2239245B (en) * 1989-12-18 1993-11-10 Wellcome Found Post-transfusional non-A non-B hepatitis viral polypeptides
WO1991014779A1 (en) * 1990-03-28 1991-10-03 Mitsui Toatsu Chemicals, Incorporated Diagnostic for hepatitis virus
JPH05506230A (ja) * 1990-04-06 1993-09-16 ジーンラブス テクノロジイズ インコーポレイテッド C型肝炎ウイルスエピトープ
EP0933426A1 (en) * 1990-06-25 1999-08-04 The Research Foundation for Microbial Diseases of Osaka University Non-a, non-b hepatitis virus genomic cdna fragments and antigen polypeptides
AU652941B2 (en) * 1990-06-25 1994-09-15 Research Foundation For Microbial Diseases Of Osaka University, The Non-A, Non-B hepatitis virus particles
EP0510952A1 (en) * 1991-04-26 1992-10-28 Immuno Japan Inc. Oligonucleotide primers and their application for high-fidelity detection of non-a, non-b hepatitis virus

Similar Documents

Publication Publication Date Title
RU93058449A (ru) Hcv геномные последовательности для диагностических и терапевтических целей
CA2108466A1 (en) Hcv genomic sequences for diagnostics and therapeutics
SG50563A1 (en) New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
RU98117084A (ru) Hcv иммунореактивные полипептидные композиции
CA2032381A1 (en) Viral agent
DK0770679T4 (da) HCV-specifikke peptider, sammensætninger dertil og anvendelse deraf
CA2290906A1 (en) Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
CA2107672A1 (en) Peptides and mixtures thereof for detecting antibodies to hepatitis c virus (hcv)
PT725824E (pt) Epitopos de celulas t humanas imunodominantes do virus da hepatite c
ATE315938T1 (de) 4'-substituierte nukleoside zur behandlung von hepatitis-c-virus-vermittelten erkrankungen
DK0804584T3 (da) Sekvenser af hepatitis C virus genotype 7 og deres anvendelse som profylaktiske, terapeutiske og diagnostiske midler
ATE195953T1 (de) Peptide zur induktion von immunantwort durch zytotoxischen t lymphocyten gegen das virus von hepatitis c
FR2677372B1 (fr) Sequences nucleotidiques et peptidiques d'un isolat de virus de l'hepatite c, applications diagnostiques et therapeutiques.
CA2045323A1 (en) Non-a, non-b hepatitis virus genomic cdna and antigen polypeptide
DE69534600D1 (de) Nukleotid- und aminosäuresequenzen der gene des hüllproteins 1 und des kernproteins von hepatitis c virus
WO1995021922A3 (en) Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use
WO1996040764A3 (en) Nucleotide and amino acid sequences of hypervariable region 1 of the envelope 2 gene of hepatitis c virus
EP1878797A3 (en) Antigenic peptides for grouping hepatitis c virus, kit comprising the same and methods for its grouping using the same
WO1999063941A3 (en) Novel hepatitis c virus peptides and uses thereof
ATE115964T1 (de) Non-a non-b sequenzen.
DE69018325D1 (de) Antigen-Protein der Sporozoit- und hepatischen Phase von P. falciparum.
RU2004104357A (ru) Вакцинный состав, потенцированный комбинацией днк и антигена
FI943929A0 (fi) Hepatiitti C-viruspeptidejä
EP0593291A3 (en) Non-structural protein of the hepatitis C virus, as well as diagnostic procedure and test kit.
TH28996B (th) "โอลิโกนิวคลีโอไทด์จำเพาะสำหรับไวรัสตับอักเสบ c